Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib
Clinical trial NCT05786430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05786430
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-07
- Primary completion
- 2026-08-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.